229 Large-scale omics profiling reveals type-2 functionality sustaining 8-year leukemia remission following CAR T cell therapy
Bai Z, Feng B, McClory S, Diorio C, Zhao Z, Tang L, Melenhorst J, June C, Grupp S, Fan R. 229 Large-scale omics profiling reveals type-2 functionality sustaining 8-year leukemia remission following CAR T cell therapy. 2023, a261-a264. DOI: 10.1136/jitc-2023-sitc2023.0229.Peer-Reviewed Original Research